亚皮克萨班与华法林在心房的功能方面的安全性和有效性:一项基于人口的双国研究
Dickson Lam1, Anish Scaria1, Jason Andrade2
1The George Institute for Global Health, UNSW Medicine & Health, Sydney, Sydney, NSW, Australia.
Kidney360
|April 9, 2025
概括
与华法林相比,在患有慢性病 (CKD) 的心房动 (AF) 患者中使用阿皮克萨班显示出类似或较低的中风和出血风险. 这表明阿皮克萨班在非透析依赖性慢性脏病的所有阶段都是安全有效的选择.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 药理学 药理学是指药理学的学科.
背景情况:
- 有限证据表明,阿皮克萨班在患有慢性脏病 (CKD) 的心房动 (AF) 患者中使用.
- 在非透析依赖性CKD的全谱中,对AF患者的阿皮克萨班与华法林的比较安全性和有效性需要评估.
研究的目的:
- 评估阿皮克萨班与华法林的安全性 (严重出血) 和有效性 (缺血性中风,死亡) 的比较.
- 评估AF患者和不同程度的非透析依赖性CKD患者的这些结果.
主要方法:
- 结合了来自澳大利亚和加拿大的5个回顾性队列 (2013-2018).
- 包括AF的成年人,新的阿皮克萨班或华法林处方,以及估计的淋巴膜过率 (eGFR) 类别:≥60,45-59,30-44和<30毫升/分钟/1.73m2.
- 排除了透析患者和脏移植接受者;使用倾向性得分匹配和Cox模型来分析一年内的结果.
主要成果:
- 在38,598名匹配患者中,阿皮克萨班在所有EGFR类别中与华法林相比,对缺血性结局的风险较低或相似.
- 在功能范围内,阿皮克萨班与较低或类似的重大出血 (内,胃肠道,其他) 风险有关.
- 在司法管辖区或eGFR类别中没有观察到结果的显著异质性.
结论:
- 在AF和非透析依赖的CKD的成年人中,apixaban与华法林相比显示出有利的风险/益处概况.
- 对于AF患者来说,阿皮克萨班似乎是一个安全有效的选择,无论他们的功能状况如何.
相关概念视频
01:17Factors Affecting Renal Clearance: Renal Impairment
36
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
36
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.1K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
568
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
568
01:11Renal Failure: Dose Adjustments
38
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
38
01:13Therapeutic Index
4.0K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
4.0K
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
147
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
147